Mark E. Boulding

2015

In 2015, Mark E. Boulding earned a total compensation of $3.3M as Executive Vice President, Chief Legal Officer and Corporate Secretary at PTC Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$168,590
Option Awards$2,739,337
Salary$409,200
Other$8,773
Total$3,325,900

Boulding received $2.7M in option awards, accounting for 82% of the total pay in 2015.

Boulding also received $168.6K in non-equity incentive plan, $409.2K in salary and $8.8K in other compensation.

Rankings

In 2015, Mark E. Boulding's compensation ranked 2,766th out of 13,638 executives tracked by ExecPay. In other words, Boulding earned more than 79.7% of executives.

ClassificationRankingPercentile
All
2,766
out of 13,638
80th
Division
Manufacturing
981
out of 5,190
81st
Major group
Chemicals And Allied Products
359
out of 1,854
81st
Industry group
Drugs
280
out of 1,528
82nd
Industry
Pharmaceutical Preparations
221
out of 1,182
81st
Source: SEC filing on April 27, 2017.

Boulding's colleagues

We found four more compensation records of executives who worked with Mark E. Boulding at PTC Therapeutics in 2015.

2015

Stuart Peltz

PTC Therapeutics

Chief Executive Officer

2015

Shane Kovacs

PTC Therapeutics

Chief Financial Officer

2015

Mark Rothera

PTC Therapeutics

Chief Commercial Officer

2015

Neil Almstead

PTC Therapeutics

Executive Vice President, Research, Pharmaceutical Operations & Technology

News

In-depth

You may also like